48
Participants
Start Date
December 5, 2019
Primary Completion Date
December 26, 2019
Study Completion Date
December 26, 2019
Combination Caplet with Loperamide HCl and Simethicone
Participants will receive combination caplet with loperamide HCl 2 mg and simethicone 125 mg as Test product A per assigned treatment sequence.
Loperamide HCl
Participants will receive loperamide HCl 2 mg tablet-lyophilizate orally as part of Reference product B per assigned treatment sequence.
Simethicone
Participants will receive Simethicone 40 mg capsule orally as part of Reference product B per assigned treatment sequence.
"Scientific and Research centre Eco-safety Limited Liability Company", Saint Petersburg
Lead Sponsor
McNeil AB
INDUSTRY